v3.26.3
Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Deficit - USD ($)
Total
Series Seed 1 Convertible Preferred Stock [Member]
Series Seed 2 Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Previously Reported [Member]
Series Seed 1 Convertible Preferred Stock [Member]
Previously Reported [Member]
Series Seed 2 Convertible Preferred Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Accumulated Other Comprehensive Loss [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Revision of Prior Period, Adjustment [Member]
Common Stock [Member]
Balance at Beginning (Shares) at Dec. 31, 2023                 3,876,721 64,065          
Balance at Beginning (Shares) at Dec. 31, 2023                     5,745,000        
Balance at Beginning (Values) at Dec. 31, 2023               $ (11,899,000) $ 37,673,000 $ 500,000 $ 1,000 $ 96,000 $ (10,000) $ (11,986,000)  
Retroactive application of the Exchange Ratio to Private Blue Laser Fusion common shares (Note 3)                             (2,117,758)
Balance at Ending (Shares) at Dec. 31, 2024   3,876,721 64,065           3,876,721 64,065          
Balance at Ending (Shares) at Dec. 31, 2024 3,627,242     3,627,242       5,745,000     5,745,000        
Balance at Ending (Values) at Dec. 31, 2024 $ (11,899,000) $ 37,673,000 $ 500,000 $ 1,000 $ 96,000 $ (10,000) $ (11,986,000) $ (11,899,000) $ 37,673,000 $ 500,000 $ 1,000 96,000 (10,000) (11,986,000)  
Retroactive application of the Exchange Ratio to Private Blue Laser Fusion common shares (Note 3)                             (2,117,758)
Stock-based compensation expense (Values) 21,000       21,000                    
Net Income (Loss) (2,247,000)           (2,247,000)                
Balance at Ending (Shares) at Mar. 31, 2025   3,876,721 64,065                        
Balance at Ending (Shares) at Mar. 31, 2025       3,627,242                      
Balance at Ending (Values) at Mar. 31, 2025 $ (14,125,000) $ 37,673,000 $ 500,000 $ 1,000 117,000 (10,000) (14,233,000)                
Balance at Beginning (Shares) at Dec. 31, 2024   3,876,721 64,065           3,876,721 64,065          
Balance at Beginning (Shares) at Dec. 31, 2024 3,627,242     3,627,242       5,745,000     5,745,000        
Balance at Beginning (Values) at Dec. 31, 2024 $ (11,899,000) $ 37,673,000 $ 500,000 $ 1,000 96,000 (10,000) (11,986,000) $ (11,899,000) $ 37,673,000 $ 500,000 $ 1,000 96,000 (10,000) (11,986,000)  
Stock-based compensation expense (Values) 85,000       85,000                    
Foreign currency translation adjustment (Values) (6,000)         (6,000)                  
Net loss (7,440,000)           (7,440,000)                
Net Income (Loss) (7,440,000)                            
Issuance of common shares upon exercise of stock option (Shares)       4,923                      
Issuance of common shares upon exercise of stock option (Values) 10,000       10,000                    
Balance at Ending (Shares) at Sep. 30, 2025   3,876,721 64,065                        
Balance at Ending (Shares) at Sep. 30, 2025       3,632,165                      
Balance at Ending (Values) at Sep. 30, 2025 (19,250,000) $ 37,673,000 $ 500,000 $ 1,000 191,000 (16,000) (19,426,000)                
Balance at Beginning (Shares) at Mar. 31, 2025   3,876,721 64,065                        
Balance at Beginning (Shares) at Mar. 31, 2025       3,627,242                      
Balance at Beginning (Values) at Mar. 31, 2025 (14,125,000) $ 37,673,000 $ 500,000 $ 1,000 117,000 (10,000) (14,233,000)                
Stock-based compensation expense (Values) 35,000       35,000                    
Foreign currency translation adjustment (Values) (3,000)         (3,000)                  
Net Income (Loss) (2,746,000)           (2,746,000)                
Issuance of common shares upon exercise of stock option (Shares)       2,714                      
Issuance of common shares upon exercise of stock option (Values) 5,000       5,000                    
Balance at Ending (Shares) at Jun. 30, 2025   3,876,721 64,065                        
Balance at Ending (Shares) at Jun. 30, 2025       3,629,956                      
Balance at Ending (Values) at Jun. 30, 2025 (16,834,000) $ 37,673,000 $ 500,000 $ 1,000 157,000 (13,000) (16,979,000)                
Stock-based compensation expense (Values) 29,000       29,000                    
Foreign currency translation adjustment (Values) (3,000)         (3,000)                  
Net Income (Loss) (2,447,000)           (2,447,000)                
Issuance of common shares upon exercise of stock option (Shares)       2,209                      
Issuance of common shares upon exercise of stock option (Values) 5,000       5,000                    
Balance at Ending (Shares) at Sep. 30, 2025   3,876,721 64,065                        
Balance at Ending (Shares) at Sep. 30, 2025       3,632,165                      
Balance at Ending (Values) at Sep. 30, 2025 $ (19,250,000) $ 37,673,000 $ 500,000 $ 1,000 191,000 (16,000) (19,426,000)                
Balance at Beginning (Shares) at Dec. 31, 2025 0 3,876,721 64,065           3,876,721 64,065          
Balance at Beginning (Shares) at Dec. 31, 2025 3,632,165     3,632,165       5,752,800     5,752,800        
Balance at Beginning (Values) at Dec. 31, 2025 $ (20,890,000) $ 37,673,000 $ 500,000 $ 1,000 231,000 (21,000) (21,101,000) $ (20,890,000) $ 37,673,000 $ 500,000 $ 1,000 231,000 (21,000) (21,101,000)  
Retroactive application of the Exchange Ratio to Private Blue Laser Fusion common shares (Note 3)                             (2,120,635)
Stock-based compensation expense (Values) 40,000       40,000                    
Foreign currency translation adjustment (Values) (5,000)         (5,000)                  
Net loss (2,091,000)           (2,091,000)                
Balance at Ending (Shares) at Mar. 31, 2026   3,876,721 64,065                        
Balance at Ending (Shares) at Mar. 31, 2026       3,632,165                      
Balance at Ending (Values) at Mar. 31, 2026 $ (22,946,000) $ 37,673,000 $ 500,000 $ 1,000 271,000 (26,000) (23,192,000)                
Balance at Beginning (Shares) at Dec. 31, 2025 0 3,876,721 64,065           3,876,721 64,065          
Balance at Beginning (Shares) at Dec. 31, 2025 3,632,165     3,632,165       5,752,800     5,752,800        
Balance at Beginning (Values) at Dec. 31, 2025 $ (20,890,000) $ 37,673,000 $ 500,000 $ 1,000 231,000 (21,000) (21,101,000) $ (20,890,000) $ 37,673,000 $ 500,000 $ 1,000 $ 231,000 $ (21,000) $ (21,101,000)  
Retroactive application of the Exchange Ratio to Private Blue Laser Fusion common shares (Note 3)                             (2,120,635)
Stock-based compensation expense (Values) 428,000       428,000                    
Foreign currency translation adjustment (Values) (10,000)         (10,000)                  
Net loss (6,461,000)           (6,461,000)                
Net Income (Loss) $ (6,461,000)                            
Issuance of common shares upon exercise of stock option (Shares) 11,679     11,679                      
Issuance of common shares upon exercise of stock option (Values) $ 24,000       24,000                    
Conversion of convertible preferred stock into common stock in connection with the Merger (Values) 38,173,000 $ (37,673,000) $ (500,000)   38,173,000                    
Conversion of convertible preferred stock into common stock in connection with the Merger (Shares)   (3,876,721) (64,065) 2,488,103                      
Issuance of preferred shares, net of issuance costs (Shares)       1,032,550                      
Issuance of preferred shares, net of issuance costs (Values) 23,713,000       23,713,000                    
Equity of Unite Acquisition 2 Corp. at the time of the exchange (Values) (780,000)           (780,000)                
Equity of Unite Acquisition 2 Corp. at the time of the exchange (Shares)       1,000,000                      
Recapitalization of Unite Acquisition 2 Corp. accumulated deficit at time of the exchange (Values) 0       (780,000)   780,000                
Issuance of restricted common shares (Shares)       $ 505,098                      
Repurchase of common shares (Shares)       (643,211)                      
Stock Repurchased During Period, Value $ (1,056,000)       (1,056,000)                    
Balance at Ending (Shares) at Sep. 30, 2026 0 0 0                        
Balance at Ending (Shares) at Sep. 30, 2026 8,026,384     8,026,384                      
Balance at Ending (Values) at Sep. 30, 2026 $ 33,141,000 $ 0 $ 0 $ 1,000 60,733,000 (31,000) (27,562,000)                
Balance at Beginning (Shares) at Mar. 31, 2026   3,876,721 64,065                        
Balance at Beginning (Shares) at Mar. 31, 2026       3,632,165                      
Balance at Beginning (Values) at Mar. 31, 2026 (22,946,000) $ 37,673,000 $ 500,000 $ 1,000 271,000 (26,000) (23,192,000)                
Stock-based compensation expense (Values) 251,000       251,000                    
Foreign currency translation adjustment (Values) (4,000)         (4,000)                  
Net loss (2,404,000)           (2,404,000)                
Issuance of common shares upon exercise of stock option (Shares)       6,313                      
Issuance of common shares upon exercise of stock option (Values) 13,000       13,000                    
Repurchase of common shares (Shares)       (138,113)                      
Balance at Ending (Shares) at Jun. 30, 2026   3,876,721 64,065                        
Balance at Ending (Shares) at Jun. 30, 2026       3,500,365                      
Balance at Ending (Values) at Jun. 30, 2026 (25,090,000) $ 37,673,000 $ 500,000 $ 1,000 535,000 (30,000) (25,596,000)                
Stock-based compensation expense (Values) 137,000       137,000                    
Foreign currency translation adjustment (Values) (1,000)         (1,000)                  
Net loss (1,966,000)           (1,966,000)                
Net Income (Loss) (1,966,000)                            
Issuance of common shares upon exercise of stock option (Shares)       5,366                      
Issuance of common shares upon exercise of stock option (Values) 11,000       11,000                    
Conversion of convertible preferred stock into common stock in connection with the Merger (Values) $ 38,173,000 $ (37,673,000) $ (500,000)   38,173,000                    
Conversion of convertible preferred stock into common stock in connection with the Merger (Shares) 2,488,103 (3,876,721) (64,065) 2,488,103                      
Issuance of preferred shares, net of issuance costs (Shares)       1,032,550                      
Issuance of preferred shares, net of issuance costs (Values) $ 23,713,000       23,713,000                    
Equity of Unite Acquisition 2 Corp. at the time of the exchange (Values) (780,000)           (780,000)                
Equity of Unite Acquisition 2 Corp. at the time of the exchange (Shares)       1,000,000                      
Recapitalization of Unite Acquisition 2 Corp. accumulated deficit at time of the exchange (Values)         (780,000)   780,000                
Issuance of restricted common shares (Shares)       $ 505,098                      
Repurchase of common shares (Shares)       (505,098)                      
Stock Repurchased During Period, Value $ (1,056,000)       (1,056,000)                    
Balance at Ending (Shares) at Sep. 30, 2026 0 0 0                        
Balance at Ending (Shares) at Sep. 30, 2026 8,026,384     8,026,384                      
Balance at Ending (Values) at Sep. 30, 2026 $ 33,141,000 $ 0 $ 0 $ 1,000 $ 60,733,000 $ (31,000) $ (27,562,000)